Product Images Rasuvo
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 10 images provide visual information about the product associated with Rasuvo NDC 59137-515 by Medexus Pharma Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Chemical Structure - rasuvo 01
Figure A - rasuvo 02
RasuV0® is a medication that comes in two strengths: 7.5 mg per 015 mL and 75 mg per 015 mL. The text also includes some illegible characters and an alphanumeric code.*
Figure B - rasuvo 03
Rasuvo® is a medication available in a package containing 10mg per 020 mL. It is suitable for men with certain medical conditions. The text also contains a lot of errors and non-English characters, making it difficult to comprehend.*
Figure C - rasuvo 04
Figure D - rasuvo 05
Not available. The text contains only a mix of gibberish, alphanumeric codes, and symbols that are difficult to understand and do not form coherent phrases or sentences.*
Figure E - rasuvo 06
Rasuvo is a medication that comes in a pre-filled syringe containing 17.5 mg per 0.35 mL. The medication is primarily used to treat rheumatoid arthritis. The text also includes various alphanumeric codes, numbers, and symbols that are not comprehensible.*
Figure F - rasuvo 07
Figure G - rasuvo 08
RasuVvo is a drug with 22.5 mg per 0.45 mL. The package has some details in it, but most of it is not readable.*
Figure H - rasuvo 09
PRINCIPAL DISPLAY PANEL - 7.5 mg Auto-Injector Carton - rasuvo 10
This is a not-available result. The scanned text is incomplete, and the output contains mostly gibberish and some fragmented text phrases.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
